- Home
- QSI vs ORMP Comparison
QSI vs ORMP Comparison
Compare QSI & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | ORMP |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | 145 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 170.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | QSI | ORMP |
|---|---|---|
| Price | $0.76 | $4.32 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 171.6K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $618.07 | N/A |
| P/E Ratio | ★ N/A | $4.90 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $0.69 | $1.98 |
| 52 Week High | $3.10 | $5.19 |
Technical Indicators
Market Signals| Indicator | QSI | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.79 | 57.66 |
| Support Level | $0.69 | $3.90 |
| Resistance Level | $1.11 | $5.10 |
| Average True Range (ATR) | 0.04 | 0.18 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 45.31 | 79.24 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.